Treatment of hypertension: Insights from the JNC-VI report

American Family Physician

Volumn 58, Issue 6, 1998, Pages 1323-1330

  Kaplan, Norman M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMLODIPINE BESYLATE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUMETANIDE; CALCIUM ANTAGONIST; CARVEDILOL; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FELODIPINE; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LABETALOL; LOSARTAN; LOSARTAN POTASSIUM; METHYLDOPA; METOLAZONE; NITRENDIPINE; POTASSIUM SPARING DIURETIC AGENT; RESERPINE; THIAZIDE DIURETIC AGENT; TORASEMIDE; UNCLASSIFIED DRUG; VERAPAMIL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; HUMAN; HYPERTENSION; LIFESTYLE; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SMOKING CESSATION; TREATMENT INDICATION; WEIGHT REDUCTION;

ALGORITHMS; ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION; LIFE STYLE; UNITED STATES;

EID: 0031740162     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Woodwell DA. National ambulatory medical care survey: 1995 summary. Adv Data 1997;295:1-25.
2. Kaplan NM. Clinical hypertension. 7th ed. Baltimore: Williams & Wilkins, 1998:9.
3. Burt VL, Culter JA, Higgins M, Horan MJ, Labarthe D, Whelton P, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension 1995;26:60-9 [published erratum in Hypertension 1996;27:1192].
4. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-46.
5. Krakoff LR, Phillips RA. White-coat hypertension. Lancet 1996;348:1443-4.
6. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997;350:757-64.
7. Pahor M, Guralnik JM, Corti MC, Foley DJ, Carbonin P, Havlik RJ. Long-term survival and use of antihypertensive medications in older persons. J Am Geriatr Soc 1995;43:1191-7.
8. Pahor M, Guralnik JM, Furberg CD, Carbonin P, Havlik R. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet 1996;347:1061-5.
9. Pahor M, Guralnik JM, Ferrucci L, Corti MC, Salive ME, Cerhan JR, et al. Calcium-channel blockers and incidence of cancer in aged populations. Lancet 1996;348:493-7.
10. Ad Hoc Subcommittee of the Liaison Committee of the World Health Organisation and the Internal Society of Hypertension. Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding. J Hypertens 1997;15:105-15.
11. Frishman WH, Bryzinski BS, Coulson LR, DeQuattro VL, Vlachakis ND, Mroczek, et al. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide. Arch Intern Med 1994;154:1461-8 [published erratum in Arch Intern Med 1995;155:709].